Related Experiment Video
Updated: May 29, 2026

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
High risk of ischemic heart disease in patients with lupus nephritis
Mikkel Faurschou1, Lene Mellemkjaer, Henrik Starklint
1Department of Rheumatology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. mikkelf@dadlnet.dk
Insights
Patients with lupus nephritis (LN) face a significantly higher risk of ischemic heart disease (IHD). Early-onset LN, in particular, is linked to a disturbingly high IHD risk compared to the general population.
Area of Science:
- Cardiology
- Nephrology
- Rheumatology
Background:
- Lupus nephritis (LN) is a severe manifestation of systemic lupus erythematosus.
- Cardiovascular complications, including ischemic heart disease (IHD), are a significant concern in LN patients.
Purpose of the Study:
- To investigate the incidence of IHD in a Danish cohort of 104 patients diagnosed with biopsy-proven lupus nephritis.
- To compare the IHD risk in LN patients to that of the general Danish population.
Main Methods:
- Utilized the Danish National Hospital Register to identify all IHD hospitalizations between 1977 and 2006.
- Calculated standardized observed-to-expected (O:E) event ratios for various IHD manifestations in the LN cohort versus the general population.
Main Results:
- The LN cohort experienced a significantly elevated overall IHD risk (O:E ratio 6.8).
- Specific IHD manifestations like angina pectoris (O:E ratio 6.0) and myocardial infarction (O:E ratio 7.9) were markedly increased.
- Younger patients (<31 years at biopsy) and those on renal replacement therapy showed exceptionally high IHD risks (O:E ratios 17.1 and 19.4, respectively).
Conclusions:
- Lupus nephritis is associated with substantially increased morbidity from ischemic heart disease.
- Patients with early-onset lupus nephritis exhibit a concerningly high risk of IHD, necessitating proactive cardiovascular monitoring and management.
Objective:
To investigate the occurrence of ischemic heart disease (IHD) in a cohort of 104 Danish patients with biopsy-proven lupus nephritis (LN).
Methods:
Information on all hospitalizations in Denmark for IHD between 1977 and 2006 was obtained from the Danish National Hospital Register. Occurrence of IHD after date of first renal biopsy in the LN cohort was compared to the occurrence of IHD in the general population by calculation of standardized ratios of observed to expected events (O:E ratios) for different manifestations of IHD registered during inpatient and outpatient hospital visits.
Results:
The median duration of followup was 14.7 (range 0.1-30.0) years. Thirty-one first-time hospitalizations for IHD occurred in the cohort, yielding an overall O:E ratio for IHD of 6.8 (95% CI 4.6-9.7). Increased risks were found for angina pectoris (O:E ratio 6.0, 95% CI 3.0-11), myocardial infarction (O:E ratio 7.9, 95% CI 3.8-15), and other IHD-related diagnoses combined (O:E ratio 6.9, 95% CI 3.3-13). A high IHD risk was observed for patients aged < 31 years at time of first renal biopsy (O:E ratio 17.1, 95% CI 9.1-29) and for patients aged 30-39 years during followup (O:E ratio 42.3, 95% CI 21-76). Patients undergoing chronic renal replacement therapy also had a pronounced risk of IHD (O:E ratio 19.4, 95% CI 7.8-40).
Conclusion:
LN is associated with markedly increased morbidity from IHD. Our findings indicate that patients with early-onset LN have a disturbingly high risk of IHD compared to the general population.
Related Concept Videos
Nephrotic Syndrome I : Introduction
Rheumatic Heart Disease IV: Nursing Management
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Rheumatic Heart Disease I: Introduction
Nephrotic Syndrome III : Nursing Management
